Clinical Study of Z-213 in Subjects With Iron-deficiency Anemia
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 29 Mar 2017
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Iron deficiency anaemia
- Focus Adverse reactions; Registrational
- Sponsors Zeria
- 24 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 15 Jul 2016 New trial record
- 12 Jul 2016 Status changed from not yet recruiting to recruiting.